Muhammad Haroon

3.0k total citations · 1 hit paper
62 papers, 1.9k citations indexed

About

Muhammad Haroon is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Muhammad Haroon has authored 62 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 19 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Muhammad Haroon's work include Spondyloarthritis Studies and Treatments (24 papers), Rheumatoid Arthritis Research and Therapies (19 papers) and Psoriasis: Treatment and Pathogenesis (16 papers). Muhammad Haroon is often cited by papers focused on Spondyloarthritis Studies and Treatments (24 papers), Rheumatoid Arthritis Research and Therapies (19 papers) and Psoriasis: Treatment and Pathogenesis (16 papers). Muhammad Haroon collaborates with scholars based in Ireland, Pakistan and United States. Muhammad Haroon's co-authors include Oliver FitzGerald, Phil Gallagher, Brian Kirby, Robert Winchester, Eric Heffernan, Jon T. Giles, Sinead Harney, Joe Devlin, Conor C. Murphy and Michael R. OʼRourke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Annals of the Rheumatic Diseases.

In The Last Decade

Muhammad Haroon

58 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis

2014 416 citations Muhammad Haroon, Phil Gallagher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muhammad Haroon Ireland	21	1.3k	1.1k	595	159	158	62	1.9k
Murat İçen Türkiye	13	672 0.5×	772 0.7×	270 0.5×	103 0.6×	280 1.8×	28	1.3k
Majed Khraishi Canada	22	1.5k 1.1×	1.2k 1.1×	725 1.2×	173 1.1×	213 1.3×	65	2.2k
C. Gaujoux-Viala France	22	2.0k 1.5×	624 0.6×	748 1.3×	162 1.0×	64 0.4×	87	2.7k
Santiago Muñoz‐Fernández Spain	27	1.2k 0.9×	463 0.4×	474 0.8×	154 1.0×	65 0.4×	75	1.8k
Lianne S. Gensler United States	27	2.5k 1.9×	1.7k 1.5×	950 1.6×	177 1.1×	111 0.7×	165	3.0k
Xavier Juanola Spain	22	1.2k 0.9×	611 0.6×	348 0.6×	114 0.7×	38 0.2×	96	1.6k
Katerina Chatzidionysiou Sweden	22	1.9k 1.4×	660 0.6×	647 1.1×	106 0.7×	57 0.4×	88	2.4k
Alexandre Sepriano Portugal	22	1.9k 1.4×	813 0.8×	544 0.9×	111 0.7×	37 0.2×	92	2.4k
Rubén Queiró Spain	30	1.9k 1.4×	1.9k 1.7×	877 1.5×	194 1.2×	425 2.7×	192	2.9k
Arijit Ganguli United States	22	439 0.3×	360 0.3×	191 0.3×	187 1.2×	227 1.4×	90	1.4k

Countries citing papers authored by Muhammad Haroon

Since Specialization

Citations

This map shows the geographic impact of Muhammad Haroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Haroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Haroon more than expected).

Fields of papers citing papers by Muhammad Haroon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Haroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Haroon. The network helps show where Muhammad Haroon may publish in the future.

Co-authorship network of co-authors of Muhammad Haroon

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Haroon. A scholar is included among the top collaborators of Muhammad Haroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Haroon. Muhammad Haroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haroon, Muhammad, et al.. (2025). Risk factors for urethrocutaneous fistula following hypospadias repair: a multisite prospective cohort study. African Journal of Urology. 31(1).

Haroon, Muhammad, et al.. (2024). An end-to-end approach to detect railway track defects based on supervised and self-supervised learning. Results in Engineering. 24. 103326–103326. 6 indexed citations

Khan, Asadullah, et al.. (2021). TAKAYASU ARTERITIS: PATTERN OF CLINICAL AND RADIOLOGICAL FEATURES, EXPERIENCE FROM PAKISTAN. Journal of Ayub Medical College Abbottabad. 34(1). 24–30. 2 indexed citations

Khan, Asadullah, et al.. (2020). Behcet’s Disease: Pakistani Experience. Pakistan Journal of Medical Sciences. 36(5). 1005–1010. 6 indexed citations

Haroon, Muhammad, et al.. (2020). Elevated CRP even at the first visit to a rheumatologist is associated with long-term poor outcomes in patients with psoriatic arthritis. Clinical Rheumatology. 39(10). 2951–2961. 15 indexed citations

Haroon, Muhammad, et al.. (2020). 5-year longitudinal study of clinical and patient-reported outcomes in acute anterior uveitis. Eye. 35(2). 651–658. 6 indexed citations

Haroon, Muhammad, et al.. (2020). Bristol rheumatoid arthritis fatigue scale is valid in patients with psoriatic arthritis and is associated with overall severe disease and higher comorbidities. Clinical Rheumatology. 39(6). 1851–1858. 4 indexed citations

Nasir, Muhammad, et al.. (2019). Role of the Clinical Pharmacist in adherence to the treatment of Multidrug-Resistant and Extensively Drug Resistant Tuberculosis. 25(1). 11–16. 2 indexed citations

Szentpétery, Ágnes, Muhammad Haroon, & Oliver FitzGerald. (2019). Cardiovascular Comorbidities in Psoriatic Disease. Rheumatology and Therapy. 7(1). 5–17. 9 indexed citations

10.

Haroon, Muhammad, et al.. (2018). High prevalence of risk factors for low bone mineral density and estimated fracture and fall risk among elderly medical inpatients: a missed opportunity. Irish Journal of Medical Science (1971 -). 188(2). 531–536. 4 indexed citations

11.

Szentpétery, Ágnes, Eric Heffernan, Martina Gogarty, et al.. (2017). Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis. Arthritis Research & Therapy. 19(1). 158–158. 29 indexed citations

12.

OʼRourke, Michael R., et al.. (2017). The Effect of Anterior Uveitis and Previously Undiagnosed Spondyloarthritis: Results from the DUET Cohort. The Journal of Rheumatology. 44(9). 1347–1354. 19 indexed citations

13.

Khan, Muhammad Asim, Muhammad Haroon, & James T. Rosenbaum. (2015). Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye. Current Rheumatology Reports. 17(9). 59–59. 44 indexed citations

14.

Haroon, Muhammad & Oliver FitzGerald. (2012). Vitamin D Deficiency: Subclinical and Clinical Consequences on Musculoskeletal Health. Current Rheumatology Reports. 14(3). 286–293. 34 indexed citations

15.

Haroon, Muhammad & Oliver FitzGerald. (2012). Pathogenetic Overview of Psoriatic Disease. PubMed. 89(0). 7–10. 11 indexed citations

16.

Haroon, Muhammad, John Ryan, & Sinead Harney. (2011). Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?. Clinical Rheumatology. 30(8). 1095–1098. 8 indexed citations

17.

Haroon, Muhammad, Patrick D. McLaughlin, Michael T. Henry, & Sinead Harney. (2011). Spontaneous Pneumomediastinum in a Patient With Anti-Centromere Antibody-Positive Limited Scleroderma. JCR Journal of Clinical Rheumatology. 17(1). 42–43. 6 indexed citations

18.

Haroon, Muhammad, Ursula Bond, Niamh Quillinan, Mark J. Phelan, & Michael J. Regan. (2010). The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics. Clinical Rheumatology. 30(6). 789–794. 22 indexed citations

19.

Haroon, Muhammad & Mark J. Phelan. (2008). A paraneoplastic case of palmar fasciitis and polyarthritis syndrome. Nature Clinical Practice Rheumatology. 4(5). 274–277. 21 indexed citations

20.

Haroon, Muhammad, Ursula Bond, & Mark J. Phelan. (2008). Sinusitis: a possible link with adalimumab. Clinical Rheumatology. 27(9). 1189–1190. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact